Sign In
Buy GOSS
$0.188
-0.0119 (-5.94%)
At Close: Jun 03, 2026
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
10:02am, Thursday, 21'st May 2026
LOS ANGELES, May 21, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Gossamer Bio, Inc. (“Gossamer�
Philadelphia, Pennsylvania--(Newsfile Corp. - May 21, 2026) - National plaintiffs' law firm Berger Montague PC announces a class action lawsuit
The Red Flags: What Insiders Allegedly Knew Before Shareholders Did NEW YORK, May 21, 2026 /PRNewswire/ -- SueWallSt announces that a securities class action has been filed against Gossamer Bio, Inc.
Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure- HBSS
09:00am, Thursday, 21'st May 2026
GOSS Investors with Losses Encouraged to Contact the Firm Before June 1st Deadline SAN FRANCISCO, May 21, 2026 /PRNewswire/ -- A securities class action lawsuit has been filed against Gossamer Bio, In
New York, New York--(Newsfile Corp. - May 20, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Gossamer Bio, Inc. (NASDAQ: GOSS) between June 16, 202
San Francisco, California--(Newsfile Corp. - May 20, 2026) - A securities class action lawsuit has been filed against Gossamer Bio, Inc. (NASDAQ: GOSS) and an executive, seeking to represent investors
SAN DIEGO, May 20, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Gossamer Bio, Inc. (NASDAQ: G
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Gossamer To Contact Him Directly To Discuss Their Options If you purchased or acquire
Alert: Claims Focus on Alleged Misrepresentations About PROSERA Trial NEW YORK, May 20, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP reminds purchasers of Gossamer Bio, Inc. (NASDAQ: GOSS) securities of
New York, New York--(Newsfile Corp. - May 19, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Gossamer Bio, Inc. (NASDAQ: GOSS) between June 16, 202
NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Gossamer Bio, Inc. (“Gossamer” or the “Company”) (NASDAQ: GOSS). Such
LOS ANGELES, May 19, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded c
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Gossamer To Contact Him Directly To Discuss Their Options If you purchased or acquire
Portnoy Law Firm Announces Class Action on Behalf of Gossamer Bio, Inc. Investors
09:05am, Tuesday, 19'th May 2026
LOS ANGELES, May 19, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Gossamer Bio, Inc., (“Gossamer” or the "Company") (NASDAQ: GOSS) investors of a class action on behalf of investors that
Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure – Hagens Berman
09:00am, Tuesday, 19'th May 2026
SAN FRANCISCO, May 19, 2026 (GLOBE NEWSWIRE) -- A securities class action lawsuit has been filed against Gossamer Bio, Inc. (NASDAQ: GOSS) and an executive, seeking to represent investors who purchase
